VEYVONDI 650 IE

VEYVONDI 650 IE is a medicine authorised by Swissmedic under authorisation number 66601. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 October 2018 and the authorisation is valid without a time limit. ATC code B02BD10 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 66601
  • ATC B02BD10
  • Biotechnological medicines
Authorisation data
Authorisation number66601
NameVEYVONDI 650 IE
Full nameVEYVONDI 650 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderTakeda Pharma AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB02BD10
First authorisation04 October 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1VEYVONDI 650 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB04 October 2018
2VEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB04 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1650 IESetB02BD1006.01.1.B
21300 IESetB02BD1006.01.1.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is VEYVONDI 650 IE authorised in Switzerland?

Yes. VEYVONDI 650 IE is authorised by Swissmedic under authorisation number 66601, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does VEYVONDI 650 IE have?

VEYVONDI 650 IE is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of VEYVONDI 650 IE?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com